Overview

In an era of unprecedented innovation in life sciences, where breakthroughs in pharmaceuticals, biotechnology, and healthcare are shaping global health and economies, ""Pharmaceutical Antitrust: An Analysis of US and EU Law"" is an indispensable guide. Edited by Mélanie Thill-Tayara and George Gordon, esteemed experts in antitrust law, this book offers a comprehensive examination of how competition laws are applied in the life sciences sector in the United States and the European Union. The book provides in-depth analysis of and practical insights regarding the effect of the complex interplay of IP, regulatory frameworks, and competition principles on issues related to marketing authorizations, exclusivities, patent acquisition and enforcement, mergers and acquisitions, collaboration agreements, pricing strategies, and distribution arrangements. Each chapter provides invaluable insights into the intricacies of antitrust, international cooperation among antitrust authorities, and the analysis of market dynamics within the pharmaceutical arena. This book is an indispensable companion for legal professionals, academics, regulators, and executives operating in the complex world of pharmaceuticals and antitrust law.

Full Product Details

9781954750104

Table of Contents

Reviews

Author Information

Mélanie Thill-Tayara is the co-managing partner of Dechert's Paris office and co-lead of the firm's Life Sciences practice. Mélanie focuses her practice on antitrust and competition law, and she regularly represents leading companies in cartel and abuse of dominant position cases before EU and French authorities and courts. In addition, Mélanie assists leading companies in merger notifications before the French and European regulators and coordinates multi-jurisdictional filings. Prior to joining Dechert in February 2016, she served as a partner for more than 20 years with two other international law firms. Before that, she was an officer at the European Commission, Directorate-General for Competition, where she participated in numerous dawn raid operations and contributed to several decisions. Named ""Litigator of the Year"" at the Global Competition Review's GCR Awards 2023, Mélanie Thill-Tayara is ranked as one of the top competition and antitrust lawyers in France by Chambers Europe, Legal 500, GCR100, Who's Who Legal: France and Best Lawyers France. George G. Gordon is a partner and the former co-chair of Dechert's antitrust/competition group and the life sciences group. He is a leading, nationally-recognized antitrust defense lawyer whose practice focuses on antitrust litigation, government investigations, and counseling. Mr. Gordon's experience includes substantial antitrust class action litigation and general antitrust litigation including a number of significant antitrust actions involving claims of monopolization, unlawful price discrimination, unlawful group boycotts, predatory pricing, and monopoly leveraging. He has also successfully represented clients in a number of non-public investigations by the Federal Trade Commission and the Department of Justice, Antitrust Division. Mr. Gordon represents life science companies in disputes arising out of licensing, collaboration, asset purchase and other agreements. In addition to representing clients in the arbitration and litigation of such disputes, Mr. Gordon has helped clients develop pre-litigation/arbitration strategies allowing them to achieve critical objectives through the successful negotiation of commercial resolutions in these matters. Since 2004, Mr. Gordon has been recognized as a top antitrust lawyer in Chambers USA, a referral guide to leading lawyers in the United States. Chambers USA writes that he is ""a very good lawyer"" who ""wins praise as 'one of the top antitrust defense lawyers'"" and that he is ""smart, reasoned and reasonable."" The Best Lawyers in America formerly named him Philadelphia Antitrust Law ""Lawyer of the Year"" and consistently recognizes him for Antitrust Law and Litigation. Benchmark Litigation recognizes him as a national ""litigation star"" -he is also a ""Leading Lawyer"" in Legal 500 and ranked as a ""Life Science Star"" in LMG Life Sciences.

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available